World's Best Scientists 2026 revealed!
Translational Oncology
H-index 30

Translational Oncology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1038 208 193 22

Additional Metrics

Number of Best Scientists*: 474
Documents by Best Scientists*: 379
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 78
SCIMAGO SJR: 1.408
Impact Factor: 4.1

Overview

Top Research Topics at Translational Oncology?

Cancer research, Internal medicine, Pathology, Cancer and Oncology are among the topics commonly tackled in the journal. Some problems in Cancer research that were presented in it overlapped with concepts under Cell culture, Cancer cell, Apoptosis, Metastasis and In vivo. Translational Oncology features In vivo research that overlaps with concepts in In vitro.

Internal medicine study tackled is connected to the field of Gastroenterology. The journal explores topics in Pathology which can be helpful for research in disciplines like Text mining, Magnetic resonance imaging and Nuclear medicine. Some problems in Cancer that were presented in Translational Oncology overlapped with concepts under Immune system and Bioinformatics.

The work on Oncology tackled in Translational Oncology brings together disciplines like Stage (cooking), Radiation therapy, Proportional hazards model and Hazard ratio.

  • Cancer research (45.62%)
  • Internal medicine (23.39%)
  • Pathology (20.88%)

What are the most cited papers published in the journal?

  • SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients (275 citations)
  • Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. (239 citations)
  • Reproducibility and Prognosis of Quantitative Features Extracted from CT Images. (204 citations)

Research areas of the most cited articles at Translational Oncology:

The most cited papers investigate areas of study like Pathology, Cancer research, Cancer, Internal medicine and Breast cancer. While work presented in the journal articles provide substantial information on Pathology, it also covers topics in Colorectal cancer, Magnetic resonance imaging, Nuclear medicine and In vivo. The most cited publications focus on Cancer research but the discussions also offer insight into other areas such as Cell growth, Carcinogenesis, Apoptosis, Immunology and Metastasis.

What topics the last edition of the journal is best known for?

  • Cancer
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The journal investigates studies in Cancer research, Apoptosis, Cancer, Multiple drug resistance and Olaparib. The Cancer research works featured in Translational Oncology incorporate elements from Cofilin 1, Cell migration, Microvesicles, Mesenchymal stem cell and In vivo. Translational Oncology focuses on Apoptosis but the discussions also offer insight into other areas such as Leukemia, Histone H3, Histone and Cord blood.

It connects research in Cancer with the related topic of Evolutionary dynamics.

The most cited articles from the last journal are:

  • Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase. (0 citations)
  • Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro. (0 citations)
  • 68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Translational Oncology (based on the number of publications) are:

  • Theodore S. Lawrence (18 papers) absent at the last edition,
  • Alexey Surov (14 papers) absent at the last edition,
  • Jeeyun Lee (13 papers) absent at the last edition,
  • Brian D. Ross (12 papers) absent at the last edition,
  • Alnawaz Rehemtulla (12 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Translational Oncology (based on the number of publications) are:

  • University of Michigan (64 papers) absent at the last edition,
  • Sun Yat-sen University (54 papers) absent at the last edition,
  • University of Texas MD Anderson Cancer Center (35 papers) absent at the last edition,
  • Zhejiang University (28 papers) absent at the last edition,
  • Fudan University (25 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2022 edition, 14.29% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 0.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 16.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.67% of all publications and 66.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

About the Journal's Impact Factor

One of the key metrics not included in the article is information on the Impact Factor of the journal, Translational Oncology. The Impact Factor can provide crucial insights into the influence and reach of a journal in its specific research field. The Impact Factor is calculated annually, and it measures the average number of times articles from a journal published in the past two years have been cited in the Journal Citation Reports (JCR) year. It is an important indicator used by researchers and institutions worldwide to evaluate and compare the relative significance of different journals within their specialized fields. Translational Oncology's most recent Impact Factor, its trend over the past years, and its ranking amid other oncology journals worldwide could add further value to this article. It would assist readers to assess the prestige and influence of the journal, as well as the wider recognition of research studies published in it. Furthermore, the Impact Factor can also hint at the journal's acceptance rate and the competitiveness of the publication process. This information can be obtained from various reputable databases including the Web of Science (Clarivate Analytics) and Scopus (Elsevier). It is essential to note that while the Impact Factor can be informative, it should not be the sole criterion for assessing a journal's quality or the worth of individual research articles. For researchers in the medical field looking for further educational advancement, this information can help determine whether publishing in this journal would be beneficial to their academic journey. For those interested in becoming Licensed Practical Nurses (LPNs), here are some highly recommended lpn programs in Georgia{anchor}.

Top Publications

  • Epithelial-Mesenchymal Transition in Cancer: A Historical Overview

    Domenico Ribatti;Roberto Tamma;Tiziana Annese

    (2020)
    702 Citations
  • PLK1 inhibition-based combination therapies for cancer management

    (2021)
    103 Citations
  • Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection

    (2022)
    67 Citations
  • Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play.

    Wenchao Zhang;Panhong Gou;Jean-Marie Dupret;Christine Chomienne

    (2021)
    60 Citations
  • The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor

    (2022)
    50 Citations
  • Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine

    Ildikó Fritz;Philippe Wagner;Håkan Olsson

    (2021)
    48 Citations
  • B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors.

    Uday B. Maachani;Umberto Tosi;David J. Pisapia;Sushmita Mukherjee

    (2020)
    46 Citations
  • Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer.

    Ashenafi Bulle;Jeroen Dekervel;Lise Deschuttere;David Nittner

    (2020)
    42 Citations
  • Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion

    Yugang Wang;Udit Singhal;Yuanyuan Qiao;Tadas Kasputis

    (2020)
    38 Citations
  • Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization.

    George Yang;Zhigang Yuan;Kamran Ahmed;Eric A. Welsh

    (2021)
    38 Citations

Related Online Degrees & Career Pathways

For those interested in advancing their medical careers, exploring related online degrees can be a strategic move. Programs like the shortest pmhnp certificate program offer a fast track to becoming a Psychiatric Mental Health Nurse Practitioner, ideal for professionals aiming to specialize in mental health care.

Nurses looking to expand their scope of practice might consider the 12-month fnp program online, a convenient path to becoming a Family Nurse Practitioner. Its online format allows working professionals to balance education with their clinical duties.

Those interested in nutrition and wellness can benefit from the best online registered dietitian programs, which provide essential knowledge for careers in dietary management and public health nutrition.

Additionally, the easiest rn to bsn online program is a popular choice for registered nurses seeking to upgrade their qualifications efficiently. This pathway enhances clinical and leadership skills, opening doors to more advanced roles within healthcare settings.

Best Scientists Contributing to This Journal